HbA1c testing market size worth approximately US$3.17 billion by 2031:

Pune, May 30, 2022 (GLOBE NEWSWIRE) — The Global HbA1c test market the size was worth USD 1.3 billion in 2021. The market valuation is expected to grow from USD 1.3 billion in 2021 to USD 3.17 billion by 2031 at a CAGR of 8.5% in 2021-2031 due to the increasing prevalence of diabetes which has led to the growing need to test and monitor glucose levels

Growth engines

Diabetes has affected millions of people around the world, and the number of people with diabetes continues to rise. According to the International Diabetes Federation, in 2019, around the world, around 463 million adults aged 20 to 79 were living with diabetes and this number is expected to reach 700 million by 2045.

The increasing prevalence of diabetes worldwide has led to an increase in the demand for testing. As the HbA1c test helps to determine the average blood sugar level over the last 2-3 months, these tests are further combined with other diagnostic test methods to derive an effective diagnosis of the disease and thus help in a decision making. inappropriate treatment decisions. The global HbA1c testing market is growing tremendously owing to factors such as relentless growth in the prevalence of diabetes, increasing rate of physician prescribing, and low testing costs.

The global HbA1c test market has been analyzed from four angles: product, technology, end user and region.

Download exclusive sample report @ https://growthplusreports.com/inquiry/request-sample/hba1c-testing-market/7692

Key industry development-

In May 2020, EKF Diagnostics signed a 3-year distribution agreement with Tosoh Europe NV for a Quo-Test HbA1c point-of-care (POC) analyzer in the Middle East and Africa. The quo-test analyzer is fully automated and quantifies HbA1c from a 4 μL sample taken from a finger prick or whole venous blood.

Stress Factors-

However, studies have shown that the presence of genetic variants of hemoglobin can affect the accuracy of HbA1c measurements. Iron deficiency anemia and vitamin B12 deficiency can cause falsely elevated HbA1c results. These factors challenge the global market adoption of HbA1c testing.

Excerpts from ‘By technological segmentation’

Based on Technology, the market has been segmented into:-

  • Ion exchange HPLC
  • Boronate Affinity Chromatography
  • Turbidimetric inhibition immunoassay
  • Direct enzymatic assay
  • Other technologies

The ion-exchange HPLC segment held the largest share of the HbA1c testing market.

Reduced accuracy, sensitivity and cost for obtaining HbA1c results are some of the advantages of using ion exchange HPLC to measure HbA1c testing.

These advantages motivate the use of ion-exchange HPLC.

Excerpts from ‘Segmentation by region’

Regionally, the global HbA1c testing market has been segmented into:-

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World (RoW).

North America held the largest share of the global HbA1c testing market.

Factors such as increasing geriatric population with diabetes coupled with increasing need for continuous blood glucose monitoring is driving the growth of HbA1c testing market. Moreover, factors such as the presence of prominent players with diverse product portfolios and large number of laboratories providing HbA1c testing also play a pivotal role in propelling the growth of this market in the region. .

Additionally, increased awareness of the availability of new tests and increasing adoption of HbA1c testing due to increased prescriptions by physicians and endocrinologists contribute to the current dominance of the North American market. Moreover, favorable reimbursements and sufficient insurance coverage also support North America’s dominance in the global HbA1c testing market.

A considerably large patient base is also a major attribute of the North American market.

There has been a steady increase in the overall prevalence of diabetes in all age groups in the region. This fact, coupled with a growing awareness of the long-term implications of diabetes in the form of different comorbidities, has led to the increasing adoption of advanced diagnostic and monitoring techniques for diabetes management and thus to the growth of HbA1c test solutions.

Ask here for more customization study @ https://growthplusreports.com/inquiry/customization/hba1c-testing-market/7692

Excerpts from “Competitive Landscape”

Key Players operating in the Global HbA1c Testing Market include:-

  • Abbott
  • Siemens Healthcare Private Limited
  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche SA
  • STP Diagnosis
  • Transasia Bio-Medical
  • Danaher
  • Trinity Biotech
  • Tosoh Corporation and among others

By product outlook:

By Technology Insights:

  • ion exchange HPLC
  • Boronate Affinity Chromatography
  • Turbidimetric inhibition immunoassay
  • Direct enzymatic assay

From the perspective of end users:

  • Hospitals & Clinics
  • Diagnostic laboratories
  • Home Care


  • Fueled by free analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative information at segment and sub-segment level
  • Trends and perspectives of the impact of Covid 19
  • Granular information at global/regional/country level
  • In-depth insights into market dynamics (drivers, restraints, opportunities) and business environment
  • Global coverage of the competitive landscape
  • Winning imperatives
  • Comprehensive coverage of “strategic developments” recorded by major market players


  • Distributor Landscape Assessment
  • Pricing information
  • Customer evaluation
  • Analysis of investments and initiatives
  • ‘Company Profile’ of key players

Buy this Premium Research Report @ https://growthplusreports.com/checkout?_token=4WMbbwaVL1BHqF0VCS0RzYSSrXk4qyxUJRyislwX&report_id=7692&license=Single

Check out other healthcare-related studies published by Growth Plus Reports:

defibrillator market By Type (Implantable Cardiac Defibrillator and External Defibrillator), End-User (Hospitals & Clinics, Pre-Hospitals, Public Access Market, Homecare Parameters, and Alternative Care Market) – Global Outlook and Forecast 2021-2031

Autoimmune Disease Diagnostics Market by product (instruments and consumables and assay kits), type (localized diagnosis of autoimmune diseases, diagnosis of systemic autoimmune diseases), type of test (routine laboratory tests, autoantibodies and immunological test and inflammatory markers ) – Global Outlook and Forecast 2021-2031

Active Pharmaceutical Ingredients (API) Market by type [Generic and Branded]Manufacturer Type [Merchant (Contract) Manufacturers and Captive (In-House) Manufacturers]Application [Cardiovascular Disease, Infectious Diseases, Oncology, Neurological Diseases, Diabetes, and Respiratory Diseases] – Global Outlook and Forecast 2021-2031

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge services company. We are proud members of the EPhMRA (European Pharmaceutical Marketing Research Association).

The Growth+ portfolio of services leverages our core capabilities in secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and game-changing solutions. that prepare them for future growth and success.

We have been recognized by the prestigious CEO Magazine as “2020’s Most Innovative Healthcare Market Research Company”.